These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19334511)

  • 21. [Comparative study of the interoceptive effects of afobazole and diazepam].
    Volkova AV; Kalinina TC; Voronina TA
    Eksp Klin Farmakol; 2010 Oct; 73(10):2-6. PubMed ID: 21254504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of afobazole on brain-ischemia-induced anxiety in rats].
    Seredenin SB; Akopian VP; Balasanian MG; Topchian AV
    Eksp Klin Farmakol; 2006; 69(2):3-5. PubMed ID: 16845930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antimutagenic properties of ubiquinone-10].
    Georgiev VN; Durnev AD; Seredenin SB
    Biull Eksp Biol Med; 1994 Sep; 118(9):270-3. PubMed ID: 7819557
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anticlastogenic activity of apo-carotene in vivo].
    Durnev AD; Tiurina LS; Guseva NV; Oreshchenko AV; Seredinin SB
    Eksp Klin Farmakol; 1997; 60(3):68-70. PubMed ID: 9324406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modification by lacidipine of the clastogenic effect of dioxidine in vivo].
    Nesterova EV; Durnev AD; Seredenin SB
    Eksp Klin Farmakol; 2000; 63(4):48-52. PubMed ID: 11022308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of novel anxiolytic agent aphobazole on coherence of the brain biopotentials in MR and MNRA rats].
    Kozhechkin SN; Sviderskaia NE; Korol'kova TA; Koshtoiants OKh; Kozhedub RG; Seredenin SB
    Eksp Klin Farmakol; 2001; 64(4):3-6. PubMed ID: 11589104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the preparation "Loshtak" on the clastogenic activity cyclophosphamide].
    Mkrtchian LN; Nersesian AK; Panosian AG
    Genetika; 1995 May; 31(5):729-31. PubMed ID: 7622032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Model study of afobazole distribution in pregnant and lactating female rats and infant rat pups].
    Shreder OV; Kolyvanov GB; Litvin AA; Bastrygin DV; Shreder ED; Solomina AS; Viglinskaia AO; Zabrodina VV; Zherdev VP; Durnev AD; Seredenin SB
    Eksp Klin Farmakol; 2010 Aug; 73(8):17-20. PubMed ID: 20919552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Afobazole Alleviates Cognitive Rigidity in Experimental Model of Autism Spectrum Disorders.
    Kapitsa IG; Kalinina AP; Alymov AA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2019 Dec; 168(2):238-241. PubMed ID: 31776949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Afobazole and Betaine on DNA Damage in Placental and Embryonic Tissues of Rats with Experimental Streptozocin Diabetes.
    Zabrodina VV; Shreder ED; Shreder OV; Durnev AD; Seredenin SB
    Bull Exp Biol Med; 2015 Oct; 159(6):757-60. PubMed ID: 26519266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Decrease of mutagenic action of cyclophosphamide by buckwheat melanin preparation].
    Baraboĭ VA; Durnev AD; Oreshchenko AV; Alekseeva TN; Ogarkov VN; Samusenok LV; Pestunovich VA
    Ukr Biokhim Zh (1999); 2004; 76(5):148-50. PubMed ID: 16100912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebrovascular effects of afobazole under conditions of combined disorders of cerebral and coronary circulation].
    Mirzoian RS; Khaĭlov NA; Gan'shina TS
    Eksp Klin Farmakol; 2010 May; 73(5):2-7. PubMed ID: 20597361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].
    Gribakina OG; Kolyvanov GB; Litvin AA; Smirnov VV; Shevchenko RV; Zherdev VP
    Eksp Klin Farmakol; 2015; 78(12):18-22. PubMed ID: 27051923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of the yeast glucomannan against cyclophosphamide-induced mutagenicity.
    Chorvatovicová D; Machová E; Sandula J; Kogan G
    Mutat Res; 1999 Jul; 444(1):117-22. PubMed ID: 10477345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparative study of the effect of afobazole on brain monoamine systems in BALB/C and C57BL/6 mice].
    Kudrin VS
    Eksp Klin Farmakol; 2006; 69(5):7-10. PubMed ID: 17153957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [STUDYING ANXIOLYTIC AND ANTIDEPRESSANT PROPERTIES OF 2,2,6,6-TETRAMETHYLPIPERIDONE DERIVATIVE.].
    Naplekova PL; Narkevich VB; Voronina TA; Kudryashov NV; Kostochka LM; Kudrin VS
    Eksp Klin Farmakol; 2016; 79(11):3-6. PubMed ID: 29791102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective anxiolytic afobazole increases the content of BDNF and NGF in cultured hippocampal HT-22 line neurons].
    Antipova TA; Sapozhnikova DS; Bakhtina LIu; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(1):12-4. PubMed ID: 19334503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of afobazole on the psychophysiological state of healthy volunteers].
    Bogdan NG; Kolotilinskaia NV; Nadorov SA; Iarkova MA; Badyshtov BA
    Eksp Klin Farmakol; 2011; 74(8):8-12. PubMed ID: 22232907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of selective anxiolytic afobazole on active caspase-3.
    Antipova TA; Sapozhnikova DS; Stepanichev MY; Onufriev MV; Gulyaeva NV; Seredenin SB
    Bull Exp Biol Med; 2010 Aug; 149(2):201-3. PubMed ID: 21113491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
    Cuevas J; Rodriguez A; Behensky A; Katnik C
    J Pharmacol Exp Ther; 2011 Oct; 339(1):161-72. PubMed ID: 21715561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.